Agios Pharmaceuticals AGIO
NASDAQ AGIO
$37.26 +0.62 (+1.68%)
As of: Oct 21, 2026 · 3:57 PM EDT

Agios Pharmaceuticals (AGIO) Capital Expenditures (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) recorded Capital Expenditures of $1.21 million in Q2 2026, up 38.5% from $875,000 a year earlier and up 57.6% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Capital Expenditures (2012 - 2026) Analysis & Trends

On a TTM basis, Agios Pharmaceuticals' Capital Expenditures came in at $4.66 million as of Jun 30, 2026, up 53.8% year-over-year; for FY2025, it came in at $4.32 million, up 156.1% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of -21.1% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $1.69 million in FY2024 (+68.7%), $999,000 in FY2023 (-79.5%), $4.88 million in FY2022 (-15.0%) and $5.74 million in FY2021 (-59.3%).
  • Quarterly Capital Expenditures has ranged from -$22,000 in Q3 2021 to $4.5 million in Q4 2021 over the past five years.
  • On a year-over-year basis, Capital Expenditures has increased for eight consecutive quarters, with growth averaging 193.7% over the last eight quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 871.1% in Q3 2023, against a decline of 97.5% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $769,000 (Q1 2026), $1.12 million (Q4 2025) and $1.56 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.32 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 322.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 1.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 140.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 533.00 Mn
10 Agios Pharmaceuticals 2.22 Bn -943.26 Mn 41.75 Mn 1.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.21 Mn
Mar 31, 2026 769,000.00
Dec 31, 2025 1.12 Mn
Sep 30, 2025 1.56 Mn
Jun 30, 2025 875,000.00
Mar 31, 2025 766,000.00
Dec 31, 2024 967,000.00
Sep 30, 2024 419,000.00
Jun 30, 2024 158,000.00
Mar 31, 2024 141,000.00
Dec 31, 2023 234,000.00
Sep 30, 2023 369,000.00
Jun 30, 2023 -3,000.00
Mar 31, 2023 399,000.00
Dec 31, 2022 113,000.00
Sep 30, 2022 38,000.00
Jun 30, 2022 1.93 Mn
Mar 31, 2022 2.80 Mn
Dec 31, 2021 4.50 Mn
Sep 30, 2021 -22,000.00
API Access

Agios Pharmaceuticals Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AGIO&period=max&api_key=YOUR_API_KEY